In this Product Explainer, Public Health Physician A/Prof John Litt AM will provide a rapid update on the recombinant (ie non-live) Herpes Zoster vaccine and outline who it is currently indicated for (10 mins).
It is essential to exclude patient barriers such as technique and adherence before concluding that the medication regime needs to be intensified. GPs are best placed to work through the complex issues with our patients
In this Product Explainer, Allergy Specialist Dr Celia Zubrinich gives a short introduction to Anapen®, used for the emergency treatment of anaphylaxis and explains how to use the Anapen® device. (6 mins).
In this Product Explainer, Paediatrician and Paediatric Immunologist A/Prof Peter Richmond explains which patients are most at risk for meningococcal B, the risk reduction benefits of meningococcal B vaccination and why it is important to have conversations with parents in which the risk/benefits of vaccination are clearly explained (5 mins).
In this Product Explainer, Prof Tony Cunningham AO will provide an update on the recombinant (ie non-live) Herpes Zoster vaccine including a practical explanation of which patients satisfy the “immunocompromised” criteria (7 mins).